Ceredex Value Advisors’s Eastman Chemical EMN Stock Holding History

Ceredex Value Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-410,832	Closed	-$41.5M	–	163
2024 Q1	$41.5M	Sell	410,832 -236,059	-36%	-$20.8M	0.73%	56
2023 Q4	$58.6M	Buy	646,891 +52,102	+9%	+$4.15M	1.02%	35
2023 Q3	$46.1M	Buy	594,789 +209,644	+54%	+$17.4M	0.81%	54
2023 Q2	$32.5M	Sell	385,145 -131,210	-25%	-$10.7M	0.52%	74
2023 Q1	$43.9M	Sell	516,355 -603,000	-54%	-$51.8M	0.68%	60
2022 Q4	$92M	Sell	1,119,355 -291,725	-21%	-$23.5M	1.42%	16
2022 Q3	$101M	Buy	1,411,080 +733,997	+108%	+$66M	1.64%	11
2022 Q2	$61.3M	Sell	677,083 -4,600	-0.7%	-$476K	0.91%	40
2022 Q1	$76.9M	Buy	+681,683	New	+$79.9M	0.92%	41

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ceredex Value Advisors's EMN Position: Q2 2024 in Review

Ceredex Value Advisors sold out of Eastman Chemical (EMN) in Q2 2024, closing a stake of 410,832 shares — an estimated $41.5M sold.

Ceredex Value Advisors first reported a position in EMN in Q1 2022 and held it in 9 quarters. The position peaked at $101M in Q3 2022. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2024.

Ceredex Value Advisors reported no remaining Eastman Chemical position as of Q2 2024 after selling out during the quarter.
Ceredex Value Advisors sold 410,832 Eastman Chemical shares in Q2 2024, an estimated $41.5M.
Ceredex Value Advisors first reported a position in Eastman Chemical in Q1 2022 and held it in 9 quarters.
Ceredex Value Advisors's Eastman Chemical position peaked at $101M in Q3 2022.
751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2024.

Based on Ceredex Value Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.